Christina M. Annunziata

ORCID: 0000-0003-2033-6532

Also affiliated with National Institutes of Health, National Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplementary Table S2 from Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis

(2023)10.1158/2767-9764.22545575

Top 100%

0DataRank

Top 100%0 citations

Lídia Hernandez, Emily M.J. Fennell, Manjari Kundu, Donna Voeller, Raj Chari +12 more

Papers

Driven by 34 papers — median percentile 0. Top paper: “Prenatal cfDNA Sequencing and Incidental Detection of Maternal Cancer”.

Prenatal cfDNA Sequencing and Incidental Detection of Maternal Cancer

New England Journal of Medicine(2024)10.1056/nejmoa2401029

N/A

1.7DataRank · unranked

42 citations

Christina M. Annunziata, Ashkan A. Malayeri, Bernadette Redd, Miroslava Pavelova, Ian S. Goldlust +4 more

Patients' perspectives on prenatal screening results that suggest maternal cancer: A qualitative analysis

Prenatal Diagnosis(2023)10.1002/pd.6406

N/A

0.607DataRank · unranked

7 citations

Skye A. Miner, Christina M. Annunziata, Diana W. Bianchi, Amy Turriff

A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma

The Oncologist(2023)10.1093/oncolo/oyad164

N/A

0.512DataRank · unranked

12 citations

Yoshimi Endo Greer, Sarah M. Jenkins, Margaret E. Gatti‐Mays, Nicole Houston, Sunmin Lee +11 more

Smac-mimetic enhances antitumor effect of standard chemotherapy in ovarian cancer models via Caspase 8-independent mechanism

Cell Death Discovery(2021)10.1038/s41420-021-00511-2

N/A

0.360DataRank · unranked

10 citations

Angie B. Dull, Soumya Korrapati, Christina M. Annunziata, Lídia Hernandez

NF-κB Signaling Modulates miR-452-5p and miR-335-5p Expression to Functionally Decrease Epithelial Ovarian Cancer Progression in Tumor-Initiating Cells

International Journal of Molecular Sciences(2023)10.3390/ijms24097826

N/A

0.330DataRank · unranked

8 citations

Brittney S. Harrington, Emma Attar, Soumya Korrapati, Jyoti Shetty, Yongmei Zhao +5 more

Prexasertib, a cell cycle checkpoint kinase 1 inhibitor, in BRCA mutant recurrent high-grade serous ovarian cancer (HGSOC): A proof-of-concept single arm phase II study.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6038

N/A

0.312DataRank · unranked

7 citations

Daniel An, Ann McCoy, Elise C. Kohn, Christina M. Annunziata, Kathryn Trewhitt +4 more

Tregs, gMDSCs, and levels of soluble MICA as prognostic biomarkers for combined NEO-201 and pembrolizumab.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.2530

N/A

0.165DataRank · unranked

2 citations

Massimo Fantini, Kwong Y. Tsang, Kevin C. Conlon, Charalampos S. Floudas, Azam Ghafoor +8 more

Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.07.031

N/A

0DataRank · unranked

31 citations

Christina M. Annunziata, John L. Hays, Liang Cao, Peter L. Choyke, Minshu Yu +8 more

First-in-human phase I study of intraperitoneally administered interferon-activated autologous monocytes in platinum-resistant or refractory ovarian cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.5_suppl.1

N/A

0DataRank · unranked

3 citations

Christina M. Annunziata, Christopher B. Cole

Phase I with expansion cohorts in a study of NEO-201 in adults with chemo-resistant solid tumors.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.129

N/A

0DataRank · unranked

2 citations

Nicole Houston, Stan Lipkowitz, Jung Min Lee, Alexandra Dos Santos Zimmer, Farah Zia +9 more

Interferons alpha and gamma with monocytes as a therapeutic strategy for ovarian cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.5_suppl.9

N/A

0DataRank · unranked

0 citations

Anna Duemler, Franklin Ning, Christina M. Annunziata

Another wrinkle with age: Aged collagen and intra‐peritoneal metastasis of ovarian cancer

Aging and Cancer(2022)10.1002/aac2.12049

N/A

0DataRank · unranked

24 citations

Tyvette S. Hilliard, Emma Sheedy, Preston Carey, Paul Wilkinson, Michael Siroky +9 more

Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0142

N/A

0DataRank · unranked

31 citations

Lídia Hernandez, Emily M.J. Fennell, Manjari Kundu, Donna Voeller, Raj Chari +12 more

Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells

Frontiers in Oncology(2022)10.3389/fonc.2022.762820

N/A

0DataRank · unranked

26 citations

Brittney S. Harrington, Rahul Kamdar, Michael J. Kruhlak, Christina M. Annunziata, Michael W. Caminear

Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1893

N/A

0DataRank · unranked

21 citations

Franklin Ning, Anna Duemler, Timothy G. Myers, Kathryn Trewhitt, Irene Ekwede +24 more

Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growth

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.102766

N/A

0DataRank · unranked

8 citations

Mariya Liyasova, Soumya Korrapati, Xu Zhang, Shashikala Ratnayake, Qingrong Chen +9 more

Phase I clinical trial of NEO-201, an anti-tumor-associated CEACAM-5/6 monoclonal antibody in solid tumors.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2531

N/A

0DataRank · unranked

2 citations

Maria Pia Morelli, Massimo Fantini, Marı́a M. Fergusson, Sharon Mavroukakis, Anjum Zaki +4 more

UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.07.509566

N/A

0DataRank · unranked

2 citations

Rahul Kamdar, Franklin Ning, Soumya Korrapati, Michael W. Caminear, Lídia Hernandez +18 more

Mitochondrial Matrix Protease ClpP Agonists inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.18.484947

N/A

0DataRank · unranked

0 citations

Lídia Hernandez, Emily M.J. Fennell, Donna Voeller, Raj Chari, Sam Gilbert +7 more

UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer

Journal of Experimental & Clinical Cancer Research(2023)10.1186/s13046-023-02820-z

N/A

0DataRank · unranked

15 citations

Rahul Kamdar, Franklin Ning, Soumya Korrapati, Michael W. Caminear, Lídia Hernandez +18 more

Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer

Research Square(2023)10.21203/rs.3.rs-3399502/v1

N/A

0DataRank · unranked

1 citations

Kei Kudo, Yoshimi Endo Greer, Teruhiko Yoshida, Brittney S. Harrington, Soumya Korrapati +6 more

Supplementary Table S2 from Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis

(2023)10.1158/2767-9764.22545575

Top 100%

0DataRank

Top 100%0 citations

Lídia Hernandez, Emily M.J. Fennell, Manjari Kundu, Donna Voeller, Raj Chari +12 more

Phase II study combining an anti-core 1 O-glycans targeting humanized monoclonal antibody NEO-201 with pembrolizumab in adults with chemo-resistant solid tumors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e14515

N/A

0DataRank · unranked

0 citations

Christopher B. Cole, Ann McCoy, Massimo Fantini, Sharon Mavroukakis, Anjum Zaki +4 more

Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer

Cancer Gene Therapy(2024)10.1038/s41417-024-00748-w

N/A

0DataRank · unranked

11 citations

Yoshimi Endo Greer, Teruhiko Yoshida, Brittney S. Harrington, Soumya Korrapati, Yusuke Shibuya +6 more

The Megacomplex protects ER-alpha from degradation by Fulvestrant in epithelial ovarian cancer

Cancer Letters(2024)10.1016/j.canlet.2024.217129

N/A

0DataRank · unranked

5 citations

Kevin Fedkenheuer, Ronak Khamar, Hua Tan, Valer Gotea, Sonam Raj +7 more

Targeting Metabolic Vulnerability by Combining NAMPT Inhibitors and Disulfiram for Treatment of Recurrent Ovarian Cancer

Research Square(2024)10.21203/rs.3.rs-4150814/v1

N/A

0DataRank · unranked

0 citations

Kei Kudo, Daniel R. Crooks, Yoshimi Endo Greer, Ye Yang, Jeffrey Brender +10 more

Rapid image deconvolution and multiview fusion for optical microscopy

Nature Biotechnology(2020)10.1038/s41587-020-0560-x

N/A

0DataRank · unranked

200 citations

Yue Li, Yijun Su, Talley J. Lambert, Damian Dalle Nogare, Mark W. Moyle +24 more

Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancer

Cell Death and Disease(2025)10.1038/s41419-025-07672-3

N/A

0DataRank · unranked

4 citations

Yoshimi Endo Greer, Daniel R. Crooks, Ye Yang, Jeffrey Brender, Teruhiko Yoshida +10 more

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline

Journal of Clinical Oncology(2020)10.1200/jco.19.02960

N/A

0DataRank · unranked

383 citations

Barbara M. Norquist, Christina Lacchetti, Deborah K. Armstrong, Rachel N. Grisham, Paul J. Goodfellow +7 more

Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline

Practical Radiation Oncology(2020)10.1016/j.prro.2020.04.002

N/A

0DataRank · unranked

303 citations

Christina M. Annunziata, Sushil Beriwal, Lisa Bradfield, Bradley A. Erickson, Emma C. Fields +12 more

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0056

N/A

0DataRank · unranked

224 citations

Alexandra S. Zimmer, Michelle R. Padget, Ashley Cimino‐Mathews, Jayakumar R. Nair, Yingmiao Liu +13 more

Leveraging locus-specific epigenetic heterogeneity to improve the performance of blood-based DNA methylation biomarkers

Clinical Epigenetics(2020)10.1186/s13148-020-00939-w

N/A

0DataRank · unranked

20 citations

Thomas R. Pisanic, Gennady Margolin, Hanna M. Petrykowska, Pornpat Athamanolap, Alexander Goncearenco +5 more

Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer

Frontiers in Oncology(2020)10.3389/fonc.2020.00805

N/A

0DataRank · unranked

13 citations

Maria Pia Morelli, Justin M. David, Monica Neuman, Lídia Hernandez, Stephen M. Hewitt +12 more

Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model

Cancers(2020)10.3390/cancers12061645

N/A

0DataRank · unranked

41 citations

Michelle Ozaki, Michael W. Caminear, Lídia Hernandez, Elizabeth Jordan, Nicholas J. Kalinowski +10 more

Christina M. Annunziata

Indexed papers

Top data-sharing exemplar

Papers